Fibromusküler Displazi

Baradhi, Krishna M., and Peter Bream. "Fibromuscular dysplasia." StatPearls [Internet]. StatPearls Publishing, 2021.

Perdu, J et al. “Inheritance of arterial lesions in renal fibromuscular dysplasia.” Journal of human hypertension vol. 21,5 (2007): 393-400. doi:10.1038/sj.jhh.1002156

Kadian-Dodov, Daniella et al. “Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.” Journal of the American College of Cardiology vol. 68,2 (2016): 176-85. doi:10.1016/j.jacc.2016.04.044

Schwartz, Arielle M., et al. "Aortic Dimensions Are Larger in Patients With Fibromuscular Dysplasia." Journal of the American Heart Association 11.12 (2022): e023858.

Wilson, James A., and R. L. Hughes. "Fibromuscular dysplasia." Emedicine neurology. Acceso el 1 (2010).

Stanley, J C et al. “Arterial fibrodysplasia. Histopathologic character and current etiologic concepts.” Archives of surgery (Chicago, Ill. : 1960) vol. 110,5 (1975): 561-6. doi:10.1001/archsurg.1975.01360110107018

Olin, Jeffrey W et al. “The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.” Circulation vol. 125,25 (2012): 3182-90. doi:10.1161/CIRCULATIONAHA.112.091223

Plouin, Pierre-François et al. “High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).” Hypertension (Dallas, Tex. : 1979) vol. 70,3 (2017): 652-658. doi:10.1161/HYPERTENSIONAHA.117.09539

Kiando, Soto Romuald et al. “PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance.” PLoS genetics vol. 12,10 e1006367. 28 Oct. 2016, doi:10.1371/journal.pgen.1006367

Gupta, Rajat M., et al. "A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression." Cell 170.3 (2017): 522-533.

Ganesh, Santhi K et al. “Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features.” FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 28,8 (2014): 3313-24. doi:10.1096/fj.14-251207

Kim, Esther S H et al. “Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia.” Journal of the American College of Cardiology vol. 62,21 (2013): 2026-2028. doi:10.1016/j.jacc.2013.07.038

Olin, Jeffrey W et al. “Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.” Circulation vol. 129,9 (2014): 1048-78. doi:10.1161/01.cir.0000442577.96802.8c

Savard, Sébastien et al. “Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics.” Circulation vol. 126,25 (2012): 3062-9. doi:10.1161/CIRCULATIONAHA.112.117499

Silhol, François et al. “Intranuclear expression of progesterone receptors in smooth muscle cells of renovascular fibromuscular dysplasia: a pilot study.” Annals of vascular surgery vol. 29,4 (2015): 830-5. doi:10.1016/j.avsg.2014.10.025

Mackay, A et al. “Smoking and renal artery stenosis.” British medical journal vol. 2,6193 (1979): 770. doi:10.1136/bmj.2.6193.770

Savard, Sébastien et al. “Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia.” Hypertension (Dallas, Tex. : 1979) vol. 61,6 (2013): 1227-32. doi:10.1161/HYPERTENSIONAHA.111.00838

O'Connor, Sarah et al. “Smoking and Adverse Outcomes in Fibromuscular Dysplasia: U.S. Registry Report.” Journal of the American College of Cardiology vol. 67,14 (2016): 1750-1. doi:10.1016/j.jacc.2016.01.058

Vasbinder, G Boudewijn C et al. “Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis.” Annals of internal medicine vol. 141,9 (2004): 674-82; discussion 682. doi:10.7326/0003-4819-141-9-200411020-00007

Gornik, Heather L et al. “First International Consensus on the diagnosis and management of fibromuscular dysplasia.” Vascular medicine (London, England) vol. 24,2 (2019): 164-189. doi:10.1177/1358863X18821816

Weinberg, Ido et al. “Anti-platelet and anti-hypertension medication use in patients with fibromuscular dysplasia: Results from the United States Registry for Fibromuscular Dysplasia.” Vascular medicine (London, England) vol. 20,5 (2015): 447-53. doi:10.1177/1358863X15584982

Nguyen, Nancy et al. “Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia.” Journal of vascular surgery vol. 66,2 (2017): 554-563. doi:10.1016/j.jvs.2017.02.049

CADISS trial investigators et al. “Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.” The Lancet. Neurology vol. 14,4 (2015): 361-7. doi:10.1016/S1474-4422(15)70018-9

Dworkin, Lance D, and Christopher J Cooper. “Clinical practice. Renal-artery stenosis.” The New England journal of medicine vol. 361,20 (2009): 1972-8. doi:10.1056/NEJMcp0809200

Whelton, Paul K., et al. "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines." Journal of the American College of Cardiology 71.19 (2018): e127-e248.

Saw, Jacqueline et al. “Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence.” Journal of the American College of Cardiology vol. 70,9 (2017): 1148-1158. doi:10.1016/j.jacc.2017.06.053

Michelis, Katherine C., et al. "Coronary artery manifestations of fibromuscular dysplasia." Journal of the American college of Cardiology 64.10 (2014): 1033-1046.

Baradhi, Krishna M., and Peter Bream. "Fibromuscular dysplasia." StatPearls [Internet]. StatPearls Publishing, 2021.

Perdu, J et al. “Inheritance of arterial lesions in renal fibromuscular dysplasia.” Journal of human hypertension vol. 21,5 (2007): 393-400. doi:10.1038/sj.jhh.1002156

Kadian-Dodov, Daniella et al. “Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.” Journal of the American College of Cardiology vol. 68,2 (2016): 176-85. doi:10.1016/j.jacc.2016.04.044

Schwartz, Arielle M., et al. "Aortic Dimensions Are Larger in Patients With Fibromuscular Dysplasia." Journal of the American Heart Association 11.12 (2022): e023858.

Wilson, James A., and R. L. Hughes. "Fibromuscular dysplasia." Emedicine neurology. Acceso el 1 (2010).

Stanley, J C et al. “Arterial fibrodysplasia. Histopathologic character and current etiologic concepts.” Archives of surgery (Chicago, Ill. : 1960) vol. 110,5 (1975): 561-6. doi:10.1001/archsurg.1975.01360110107018

Olin, Jeffrey W et al. “The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.” Circulation vol. 125,25 (2012): 3182-90. doi:10.1161/CIRCULATIONAHA.112.091223

Plouin, Pierre-François et al. “High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).” Hypertension (Dallas, Tex. : 1979) vol. 70,3 (2017): 652-658. doi:10.1161/HYPERTENSIONAHA.117.09539

Kiando, Soto Romuald et al. “PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance.” PLoS genetics vol. 12,10 e1006367. 28 Oct. 2016, doi:10.1371/journal.pgen.1006367

Gupta, Rajat M., et al. "A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression." Cell 170.3 (2017): 522-533.

Ganesh, Santhi K et al. “Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features.” FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 28,8 (2014): 3313-24. doi:10.1096/fj.14-251207

Kim, Esther S H et al. “Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia.” Journal of the American College of Cardiology vol. 62,21 (2013): 2026-2028. doi:10.1016/j.jacc.2013.07.038

Olin, Jeffrey W et al. “Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.” Circulation vol. 129,9 (2014): 1048-78. doi:10.1161/01.cir.0000442577.96802.8c

Savard, Sébastien et al. “Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics.” Circulation vol. 126,25 (2012): 3062-9. doi:10.1161/CIRCULATIONAHA.112.117499

Silhol, François et al. “Intranuclear expression of progesterone receptors in smooth muscle cells of renovascular fibromuscular dysplasia: a pilot study.” Annals of vascular surgery vol. 29,4 (2015): 830-5. doi:10.1016/j.avsg.2014.10.025

Mackay, A et al. “Smoking and renal artery stenosis.” British medical journal vol. 2,6193 (1979): 770. doi:10.1136/bmj.2.6193.770

Savard, Sébastien et al. “Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia.” Hypertension (Dallas, Tex. : 1979) vol. 61,6 (2013): 1227-32. doi:10.1161/HYPERTENSIONAHA.111.00838

O'Connor, Sarah et al. “Smoking and Adverse Outcomes in Fibromuscular Dysplasia: U.S. Registry Report.” Journal of the American College of Cardiology vol. 67,14 (2016): 1750-1. doi:10.1016/j.jacc.2016.01.058

Vasbinder, G Boudewijn C et al. “Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis.” Annals of internal medicine vol. 141,9 (2004): 674-82; discussion 682. doi:10.7326/0003-4819-141-9-200411020-00007

Gornik, Heather L et al. “First International Consensus on the diagnosis and management of fibromuscular dysplasia.” Vascular medicine (London, England) vol. 24,2 (2019): 164-189. doi:10.1177/1358863X18821816

Weinberg, Ido et al. “Anti-platelet and anti-hypertension medication use in patients with fibromuscular dysplasia: Results from the United States Registry for Fibromuscular Dysplasia.” Vascular medicine (London, England) vol. 20,5 (2015): 447-53. doi:10.1177/1358863X15584982

Nguyen, Nancy et al. “Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia.” Journal of vascular surgery vol. 66,2 (2017): 554-563. doi:10.1016/j.jvs.2017.02.049

CADISS trial investigators et al. “Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.” The Lancet. Neurology vol. 14,4 (2015): 361-7. doi:10.1016/S1474-4422(15)70018-9

Dworkin, Lance D, and Christopher J Cooper. “Clinical practice. Renal-artery stenosis.” The New England journal of medicine vol. 361,20 (2009): 1972-8. doi:10.1056/NEJMcp0809200

Whelton, Paul K., et al. "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines." Journal of the American College of Cardiology 71.19 (2018): e127-e248.

Saw, Jacqueline et al. “Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence.” Journal of the American College of Cardiology vol. 70,9 (2017): 1148-1158. doi:10.1016/j.jacc.2017.06.053

Michelis, Katherine C., et al. "Coronary artery manifestations of fibromuscular dysplasia." Journal of the American college of Cardiology 64.10 (2014): 1033-1046.